The effect of the inhaled PDE4 inhibitor CHF6001 on allergen-induced inflammation in asthmatics

被引：0
|
作者：
Singh, Dave
Leaker, Brian
Boyce, Malcom
Nandeuil, Marie -Anna
Collarini, Sara
Mariotti, Fabrizia
Santoro, Debora
Barnes, Peter J.
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Anti-inflammatory; COPD; -; management; Pharmacology;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The Effect Of The Inhaled Pde4 Inhibitor Chf6001 On Allergen-Induced Inflammation In Asthmatic Subjects
    Singh, D.
    Leaker, B. R.
    Boyce, M.
    Nandeuil, M. A.
    Collarini, S.
    Mariotti, F.
    Santoro, D.
    Barnes, P. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [2] Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
    Singh, Dave
    Beeh, Kai Michael
    Colgan, Brendan
    Kornmann, Oliver
    Leaker, Brian
    Watz, Henrik
    Lucci, Germano
    Geraci, Silvia
    Emirova, Aida
    Govoni, Mirco
    Nandeuil, Marie Anna
    RESPIRATORY RESEARCH, 2019, 20 (01)
  • [3] Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
    Dave Singh
    Kai Michael Beeh
    Brendan Colgan
    Oliver Kornmann
    Brian Leaker
    Henrik Watz
    Germano Lucci
    Silvia Geraci
    Aida Emirova
    Mirco Govoni
    Marie Anna Nandeuil
    Respiratory Research, 20
  • [4] In vivo efficacy of CHF6001, an inhaled PDE4 inhibitor with a wide therapeutic window
    Villetti, Gino
    Bolzoni, Pier Tonino
    Bassani, Franco
    Bergamaschi, Marco
    Caruso, Paola Lorenza
    Battipaglia, Loredana
    Sala, Angelo
    Facchinetti, Fabrizio
    Carnini, Chiara
    Civelli, Maurizio
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [5] Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study
    Dave Singh
    Aida Emirova
    Catherine Francisco
    Debora Santoro
    Mirco Govoni
    Marie Anna Nandeuil
    Respiratory Research, 21
  • [6] Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study
    Singh, Dave
    Emirova, Aida
    Francisco, Catherine
    Santoro, Debora
    Govoni, Mirco
    Nandeuil, Marie Anna
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [7] Evaluation of the Effects of CHF6001, an Inhaled PDE4 Inhibitor, on Cardiac Repolarization and Cardiac Arrhythmias in Healthy Volunteers
    Ferrari, Antonio
    Compagnoni, Anna
    Nandeuil, Anne
    Maison-Blanche, Pierre
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 68 (01) : 41 - 48
  • [8] Efficacy and Safety of CHF6001, A Novel Inhaled PDE4 Inhibitor in COPD: The Pioneer Dose Finding Study
    Singh, D.
    Nandeuil, M. A.
    Pigeon-Francisco, C.
    Emirova, A.
    Santoro, D.
    Biondaro, S.
    Cohuet, G.
    Govoni, M.
    Petruzzelli, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] Safety, Tolerability And Pharmacokinetic Profile Of Chf6001, A Novel Selective Inhaled Pde4 Inhibitor, In Healthy Volunteers
    Nandeuil, M. -A.
    Mariotti, F.
    Lucci, G.
    Santoro, D.
    Poli, G.
    Acerbi, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [10] Effect of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor (PDE4i) on markers of inflammation in COPD patients
    Singh, Dave
    Govoni, Mirco
    Bassi, Michele
    Beeh, Kai Michael
    Colgan, Brendan
    Kornmann, Oliver
    Laeker, Brian
    Watz, Henrik
    Lucci, Germano
    Geraci, Silvia
    Rocco, Emanuele Calabro
    Emirova, Aida
    Nandeuil, Marie Anna
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345